Results 61 to 70 of about 11,862,011 (403)

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database

BMC Dermatology, 2018
BackgroundBiological therapies (BTs) including infliximab (IFX), adalimumab (ADL), secukinumab (SCK) and ustekinumab (UST) are approved in Japan for the treatment of psoriasis.
R. Sruamsiri, K. Iwasaki, W. Tang, J. Mahlich   +3 more
semanticscholar   +1 more source

Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report

Case Reports in Dermatology, 2020
Alopecia areata (AA) is the most common immune-mediated hair loss disorder with a life-time prevalence of 2%. The pathogenesis of AA is not completely understood, but interferon gamma (INF-γ) and Janus kinases (JAK) may play a key role.
Tanja Todberg, Nikolai Dyrberg Loft, Claus Zachariae   +2 more
doaj   +1 more source

From pathogenesis to current treatment of the cutaneous psoriasis - a literature review

Journal of Education, Health and Sport, 2023
Introduction: Psoriasis is a chronic inflammatory autoimmune disease that can be divided into several subtypes based on the areas of the body occupied by the lesions and the severity of the disease.
Wiktoria Jakubowska, Piotr Pisera, Aleksandra Kiełkowicz, Filip Pactwa, Zuzanna Popińska, Daniel Ślusarczyk, Bartłomiej Żmuda, Michał Żuberek   +7 more
doaj   +1 more source

Diverse Treatment Goals in Psoriatic Arthritis: Insights From Participants in the PARC Cohort

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to examine patient‐reported treatment goals among individuals with psoriatic arthritis. Methods Participants in the Psoriatic Arthritis Research Consortium completed standardized assessments, including patient‐reported outcome (PROs) instruments, between 2017 and 2020.
Astia Allenzara, Kathleen Bush, M. Elaine Husni, Soumya M. Reddy, Jose U. Scher, Ethan Craig, Joelle Koplin, Jessica A. Walsh, Alexis Ogdie   +8 more
wiley   +1 more source

Disseminated eruptive giant mollusca contagiosa in an adult psoriasis patient during efalizumab therapy [PDF]

, 2008
Molluscum contagiosum is a common viral skin infection in children with atopic diathesis and not rare in HIV patients. We report a 45-year-old psoriasis patient who developed eruptive mollusca contagiosa during an antipsoriatic treatment with efalizumab.
Alexander Vasilevic Kuznetsov, Jö, Lim KS, Michael Flaig, Papp KA, Peter Weisenseel, Vozmediano JM, Wachi K   +7 more
core   +1 more source

Moderate to severe psoriasis treatment challenges through the era of biological drugs*

Anais Brasileiros de Dermatologia, 2017
Biological therapy has revolutionized moderate to severe psoriasis treatment. However, despite being more effective than conventional systemic treatments, some patients do not respond or lose response to biotechnological treatments or develop drug ...
J. Vide, S. Magina
semanticscholar   +1 more source

Longitudinal Relationship Between Pain and Depression in People With Inflammatory Arthritis: A Narrative Review

Arthritis Care &Research, EarlyView.
As many patients with inflammatory arthritis (IA) have chronic pain, understanding how to best assess and manage pain in IA is a priority. Comorbid depression is prevalent in adults with IA, affecting 15% to 39% of people. Although pain and depression are thought to be associated in IA, this concept is largely based on cross‐sectional data.
Natasha Cox, Saeed Farooq, Helen Twohig, Ian C. Scott   +3 more
wiley   +1 more source

"I don't want to manage it, I want to get rid of it" : a narrative analysis of living with chronic plaque psoriasis, and an investigation into vitamin D as a treatment : a thesis presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Nutritional Science at Massey University, Albany, New Zealand [PDF]

, 2017
As a chronic skin disease, plaque psoriasis can cause significant psychosocial, emotional and physical burden. Psoriasis sufferers perceive others as lacking understanding around what it is like to live with this condition, and there has been little ...
Ingram, Michelle Anne
core  

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations

Journal of the European Academy of Dermatology and Venereology, 2020
This evidence‐ and consensus‐based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual.
A. Nast, C. Smith, P. Spuls, G. Avila Valle, Z. Bata‐Csörgö, H. Boonen, E. D. De Jong, I. García-Doval, P. Gisondi, D. Kaur-Knudsen, S. Mahil, T. Mälkönen, J. Maul, S. Mburu, U. Mrowietz, K. Reich, É. Remenyik, K. Rønholt, P. Sator, Marcus Schmitt-Egenolf, M. Sikora, K. Strömer, O. Sundnes, D. Trigos, G. E. van der Kraaij, N. Yawalkar, C. Dressler   +26 more
semanticscholar   +1 more source

Metabolic Consequences of Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Patients with rheumatoid arthritis (RA) may have metabolic disruption, which can contribute to adverse long‐term outcomes, for multiple reasons. Patients with RA appear to have a higher risk of sarcopenia, type 1 and type 2 diabetes mellitus, metabolic syndrome, and hypertension. Systemic inflammation in RA can cause a “lipid paradox,” with reduced low‐
Stevie Barry, Emily Sheng, Joshua F. Baker   +2 more
wiley   +1 more source